MITA

Medical Imaging & Technology Alliance, A division of NEMA.

[MITA @MITAtoday]

With hundreds of thousands of devices in use, NEMA’s DICOM® Standard is at the core of modern medical imaging—from breast cancer detection to cardiac testing. It’s recognized worldwide as the gold standard for digital medical communication. https://t.co/iOBLryf7pw #DICOM

[MITA @MITAtoday]

NEMA’s DICOM® Standard has transformed how doctors diagnose and treat patients. Whether it’s an emergency X-ray or a routine MRI, DICOM® makes sure the image quality and data are always reliable. https://t.co/JGpzQVlEV1 #DICOM

[MITA @MITAtoday]

NEMA’s DICOM® Standard enables medical professionals to quickly access, share, and analyze high-quality images—improving patient care every day. It’s the global language of digital imaging, used in nearly every radiology department. https://t.co/JGpzQVlEV1 #DICOM

[MITA @MITAtoday]

From radiology to cardiology and even dentistry, NEMA’s DICOM® Standard powers the technology behind medical imaging devices worldwide. With billions of images in use, DICOM® keeps healthcare connected and efficient. https://t.co/JGpzQVlEV1 #DICOM

[MITA @MITAtoday]

Did you know? NEMA first published the DICOM® Standard over 30 years ago, setting the foundation for digital imaging in radiology and other medical fields. Today, it’s one of the most widely used healthcare messaging standards in the world. https://t.co/THiAVlAAO8 #DICOM

[MITA @MITAtoday]

MITA applauds @CMSGov for finalizing Medicare payment changes for diagnostic radiopharmaceuticals in its Hospital Outpatient Prospective Payment System (OPPS) rule. https://t.co/5kNRr6jXZ7

[MITA @MITAtoday]

For almost 40 years, NEMA’s DICOM® Standard has revolutionized medical imaging. From X-rays to MRIs, DICOM® ensures seamless communication and data quality across radiology, cardiology, and beyond. It’s a game-changer in healthcare! https://t.co/JGpzQVlEV1 #DICOM

[MITA @MITAtoday]

MITA is urging the Food and Drug Administration (FDA) to maintain its “one stability, one facility” approach to inspections for positron emission tomography (PET) drugs. https://t.co/lxrfo7ANBf

[MITA @MITAtoday]

The Centers for Medicare & Medicaid Services’ 2025 proposed hospital #OPPS rule is out -- MITA applauds @CMSGov for recognizing important FDA-approved diagnostic radiopharmaceuticals as drugs under the Medicare Hospital Outpatient Setting. Our statement: https://t.co/D8CiIkR5pr

[MITA @MITAtoday]

MITA applauds decision by US Court of Appeals: “Our lifesaving technologies depend on copyright protections that ensure repairs are made by approved technicians and government rulemakings impacting those protections should be subject to judicial review.” https://t.co/8ZNy6STIv0

[MITA @MITAtoday]

"We are proud to stand alongside more than 120 organizations in support of the FIND Act, which will help ensure patients have access to the latest diagnostic nuclear medicine procedures and technologies.” -- Sue Bunning, Managing Director, MITA’s PET Group https://t.co/JnNAJjW1Ww

[MITA @MITAtoday]

MITA appreciates the @HouseCommerce Health Subcommittee for advancing the FIND Act (HR 1199/S 1544) to the full Committee and thanks sponsors @DrNealDunnFL2, @RepGregMurphy, @RepScottPeters and @RepTerriSewell for moving this important legislation forward https://t.co/Hdnv0twStz

[MITA @MITAtoday]

MITA appreciates the @HouseCommerce Health Subcommittee for advancing the FIND Act (HR 1199/S 1544) to the full Committee and thanks sponsors @DrNealDunnFL2, @RepGregMurphy, @RepScottPeters and @RepTerriSewell for moving this important legislation forward https://t.co/Hdnv0twStz

[Dr. Neal Dunn @DrNealDunnFL2]

I’m thrilled to announce that my bill, the FIND Act, passed the @HouseCommerce Subcommittee on Health.

This legislation will help patients gain early access to life-saving scans for prostate cancer and many other conditions. We’re one step closer to signing this into law!

[MITA @MITAtoday]

Happy New Year!

[MITA @MITAtoday]

The medical imaging equipment industry utilizes a complex international supply chain to manufacture and maintain specialized and complex imaging devices. https://t.co/0g43tt3Pue

[MITA @MITAtoday]

#RighttoRepair would create new and unnecessary risks to patients, operators, and hospitals by allowing any unregulated third-party business to service and access proprietary information about medical imaging devices. https://t.co/DEb3bQFLZS

[MITA @MITAtoday]

ICYMI: CMS removed the national coverage determination that limits patients’ ability to qualify for new drugs, giving people with Alzheimer’s disease symptoms a better path to treating the condition. https://t.co/gNBu2SMI8L

[MITA @MITAtoday]

Early detection is essential to preventing diseases from progressing and maximizing treatment options. https://t.co/PvPyP7HwxW

[MITA @MITAtoday]

Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic patients and were less frequently tested with MRI, according to new research. https://t.co/30LQJtqjhG

[MITA @MITAtoday]

MITA supports the development of a reimbursement framework by the Centers for Medicare & Medicaid Services that recognizes the costs of AI-enabled medical devices for the purpose of calculating annual Medicare reimbursement amounts. https://t.co/5ybTf4602q

[MITA @MITAtoday]

Using PET scans, researchers found that low levels of dopamine in the heart were strong predictors of later development of Parkinson’s disease or dementia with Lewy bodies. Learn more: https://t.co/CfTjtLx3Vv